NPCE (NeuroPace) Other Gross PPE: $11.65 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NPCE NeuroPace Inc NPCE
70 GF Score
Price $14.05
GF Value $12.59
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is NeuroPace Other Gross PPE?

NeuroPace NPCE +1.23% 70 Other Gross PPE is $11.65 Mil as of Jun. 2026. GuruFocus rates NPCE with a GF Score™ of 70/100 and a GF Value™ of $12.59 (Modestly Overvalued). The stock has 3 warning signs investors should review.

NeuroPace's Other Gross PPE for the quarter that ended in Jun. 2026 was $11.65 Mil.

NeuroPace's quarterly Other Gross PPE declined from Dec. 2025 ($12.57 Mil) to Mar. 2026 ($12.11 Mil) and declined from Mar. 2026 ($12.11 Mil) to Jun. 2026 ($11.65 Mil).

NeuroPace's annual Other Gross PPE declined from Dec. 2023 ($15.83 Mil) to Dec. 2024 ($14.28 Mil) and declined from Dec. 2024 ($14.28 Mil) to Dec. 2025 ($12.57 Mil).

NeuroPace Other Gross PPE Historical Data

* Premium members only.

The historical data trend for NeuroPace's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeuroPace Other Gross PPE Chart

NeuroPace Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Gross PPE
Get a 7-Day Free Trial 2.40 17.24 15.83 14.28 12.57

NeuroPace Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.44 13.01 12.57 12.11 11.65
NPCE
70GF Score
NeuroPace Inc NPCE
Other Gross PPE is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NeuroPace Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Frequently Asked Questions Learn more about Other Gross PPE →
What does a Other Gross PPE of $11.65 Mil mean?
NeuroPace (NPCE) has a Other Gross PPE of $11.65 Mil as of Jun. 2026. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on NeuroPace and its competitors.
Is NeuroPace's Other Gross PPE too high?
NeuroPace's current Other Gross PPE is $11.65 Mil. Overall, NeuroPace has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NeuroPace's Other Gross PPE compare to SENS and CLPT?
NeuroPace's Other Gross PPE of $11.65 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Gross PPE for a Medical Devices & Instruments company?
A good Other Gross PPE depends on the Medical Devices & Instruments industry context. However, Other Gross PPE should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Gross PPE mean?
A high Other Gross PPE can signal that a stock is expensive relative to its fundamentals. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on NeuroPace and its competitors. NeuroPace's current Other Gross PPE is $11.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeuroPace stock overvalued right now?
Based on GuruFocus' analysis, NeuroPace (NPCE) is currently considered Modestly Overvalued. The stock's GF Value™ is $12.59, compared to a current price of $14.05 — trading 11.6% above its estimated fair value. The current Other Gross PPE is $11.65 Mil. NeuroPace's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Gross PPE calculated?
Other Gross PPE is calculated from a company's financial statements. For NeuroPace (NPCE), the current Other Gross PPE is $11.65 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NeuroPace (NPCE) Overvalued in 2026?

Based on GuruFocus' analysis, NeuroPace stock appears to be overvalued. The current stock price of $14.05 is trading 11.6% above its estimated GF Value™ of $12.59. GuruFocus considers NeuroPace to be Modestly Overvalued.

Key valuation signals for NPCE:

  • Other Gross PPE: $11.65 Mil
  • GF Value™: $12.59 vs. price of $14.05 (11.6% above fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the NPCE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NeuroPace Business Description

Address 455 N. Bernardo Avenue, Mountain View, CA, USA, 94043
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
70GF Score

Get the complete analysis for NPCE

Other Gross PPE is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.05
Price
$12.59
GF Value